Antibodies to human cytomegalovirus structural polypeptides during primary infection.
This study aimed at broadening the understanding of the immunogenic potential of cytomegalovirus (CMV) structural polypeptides during natural infection and to ascertain their possible use in serological diagnosis. Immunoblotting was used to analyse the appearance and development of serum IgG and IgM against human CMV structural polypeptides in sequential sera from renal transplant recipients during the first 1-3 months of primary CMV infection. The results showed that the first IgG to appear is specific for a polypeptide of 66 kDa and these antibodies appear either alone or together with others against another polypeptide of 82 kDa. IgG to the 150 kDa protein appears at least one week later. The first IgM to appear reacts preferentially with a 38 and 66 kDa polypeptide. The early detection of antibody against the major viral antigenic proteins in the diagnosis of CMV primary infection is discussed.
Landini
M P
MP
Institute of Microbiology, Faculty of Medicine, University of Bologna, Italy.
Rossier
E
E
Schmitz
H
H
D000914:Antibodies, Viral / Q000032:analysis / Q000096:biosynthesis*; D000956:Antigens, Viral; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D016030:Kidney Transplantation; D014764:Viral Proteins / Q000276:immunology; D015678:Viral Structural Proteins
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014764:Viral Proteins; D015678:Viral Structural Proteins